Update on capecitabine alone and in combination regimens in colorectal cancer patients
- PMID: 21129610
- DOI: 10.1016/S0305-7372(10)70020-7
Update on capecitabine alone and in combination regimens in colorectal cancer patients
Abstract
Capecitabine is an orally administered fluoropyrimidine carbamate which has been developed as a prodrug of 5-FU with the goal to improve its tolerability and intratumoral drug concentration. The review aims to provide an evidence-based update of clinical trials investigating the clinical efficacy, adverse-event profile, dosage and administration of this drug, alone or in combination with conventional chemotherapeutics and/or new target-oriented drugs, in the management of colorectal cancer patients.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Update on clinical data combining capecitabine with targeted agents in newly diagnosed colorectal cancer.Clin Colorectal Cancer. 2007 Dec;7 Suppl 1:S16-20. doi: 10.3816/ccc.2008.s.003. Clin Colorectal Cancer. 2007. PMID: 18361802 Review.
-
Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.Semin Oncol. 2005 Feb;32(1):43-51. doi: 10.1053/j.seminoncol.2004.09.028. Semin Oncol. 2005. PMID: 15726505 Review.
-
Common side effects and interactions of colorectal cancer therapeutic agents.J Pract Nurs. 2011 Spring;61(1):7-20. J Pract Nurs. 2011. PMID: 21751717 Review. No abstract available.
-
Current status of capecitabine in the treatment of colorectal cancer.Oncology (Williston Park). 2002 Dec;16(12 Suppl No 14):16-22. Oncology (Williston Park). 2002. PMID: 12520635 Review.
-
Dosing considerations for capecitabine-irinotecan regimens in the treatment of metastatic and/or locally advanced colorectal cancer.Am J Clin Oncol. 2010 Jun;33(3):307-13. doi: 10.1097/COC.0b013e3181d27361. Am J Clin Oncol. 2010. PMID: 20375835 Review.
Cited by
-
Oral versus intravenous fluoropyrimidines for colorectal cancer.Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD008398. doi: 10.1002/14651858.CD008398.pub2. Cochrane Database Syst Rev. 2017. PMID: 28752564 Free PMC article.
-
Can You Determine the Cause of This Patient's Skin Changes?J Adv Pract Oncol. 2012 Sep;3(5):343-4. J Adv Pract Oncol. 2012. PMID: 25031965 Free PMC article. Review. No abstract available.
-
A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer.Oncotarget. 2016 Dec 20;7(51):84533-84543. doi: 10.18632/oncotarget.13023. Oncotarget. 2016. PMID: 27811367 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical